Crude odds ratios for DVT, by TFPI level
. | Patients, n = 426 . | Controls, n = 397 . | OR (95% CI) . |
|---|---|---|---|
| TFPI-free antigen | |||
| 10th percentile | 1.7 (1.1-2.6) | ||
| Above | 359 | 358 | — |
| At or below | 67 | 39 | — |
| 5th percentile | 2.1 (1.1-4.1) | ||
| Above | 384 | 378 | — |
| At or below | 42 | 19 | — |
| 2nd percentile | 2.2 (0.89-5.3) | ||
| Above 2nd | 410 | 390 | — |
| At or below 2nd | 16 | 7 | — |
| TFPI total antigen | |||
| 10th percentile | 1.5 (0.98-2.3) | ||
| Above | 366 | 358 | — |
| At or below | 60 | 39 | — |
| 5th percentile | 2.1 (1.1-4.1) | ||
| Above | 392 | 378 | — |
| At or below | 34 | 19 | — |
| 2nd percentile | 3.0 (1.3-7.2) | ||
| Above | 404 | 390 | — |
| At or below | 22 | 7 | — |
| TFPI activity | |||
| 10th percentile | 1.1 (0.73-1.8) | ||
| Above | 377 | 356 | — |
| At or below | 49 | 41 | — |
| 5th percentile | 1.6 (0.87-2.8) | ||
| Above | 395 | 378 | — |
| At or below | 31 | 19 | — |
| 2nd percentile | 2.4 (1.1-5.1) | ||
| Above | 401 | 387 | — |
| At or below | 25 | 10 | — |
. | Patients, n = 426 . | Controls, n = 397 . | OR (95% CI) . |
|---|---|---|---|
| TFPI-free antigen | |||
| 10th percentile | 1.7 (1.1-2.6) | ||
| Above | 359 | 358 | — |
| At or below | 67 | 39 | — |
| 5th percentile | 2.1 (1.1-4.1) | ||
| Above | 384 | 378 | — |
| At or below | 42 | 19 | — |
| 2nd percentile | 2.2 (0.89-5.3) | ||
| Above 2nd | 410 | 390 | — |
| At or below 2nd | 16 | 7 | — |
| TFPI total antigen | |||
| 10th percentile | 1.5 (0.98-2.3) | ||
| Above | 366 | 358 | — |
| At or below | 60 | 39 | — |
| 5th percentile | 2.1 (1.1-4.1) | ||
| Above | 392 | 378 | — |
| At or below | 34 | 19 | — |
| 2nd percentile | 3.0 (1.3-7.2) | ||
| Above | 404 | 390 | — |
| At or below | 22 | 7 | — |
| TFPI activity | |||
| 10th percentile | 1.1 (0.73-1.8) | ||
| Above | 377 | 356 | — |
| At or below | 49 | 41 | — |
| 5th percentile | 1.6 (0.87-2.8) | ||
| Above | 395 | 378 | — |
| At or below | 31 | 19 | — |
| 2nd percentile | 2.4 (1.1-5.1) | ||
| Above | 401 | 387 | — |
| At or below | 25 | 10 | — |
Oral contraceptive users at blood sampling were excluded.